Glycopyrronium Bromide

5 trials 1 recruiting RRespiratory

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

3 Completed trials

5 Sponsors

7 Countries

Phase II

Phase IV

Phase II: 2 Phase IV: 3

Indications tested

Asthma 3 Chronic obstructive pulmonary disease 1

Sponsors using this IMP

AstraZeneca AB 1 Fundacio Privada Mon Clinic Barcelona 1 General Practitioners Research Institute B.V. 1 Hospices Civils De Lyon 1 Novartis Pharma AG 1

All trials

5 total

A Phase II study to investigate lung function with 2 different doses of inhaled glycopyrronium taken with BFF compared to BFF in participant… Pending

2025-524914-26-00 Phase II 3 countries AstraZeneca AB
Efficacy, Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With… Recruiting

2024-511382-11-00 Phase II 4 countries Novartis Pharma AG
THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICA… Ended

2023-507304-32-00 Phase IV 1 country Fundacio Privada Mon Clinic Barcelona
Symptoms control and adhErenCe assessment during treatment with mepolizUmab new pREfilled devices. SECURE Ended

2022-501029-19-00 Phase IV 1 country Hospices Civils De Lyon
TRACkER trial Ended

2023-508300-37-00 Phase IV 1 country General Practitioners Research Institute B.V.

Showing 1–5 of 5 trials

← All drugs A–Z